FeesSafety
Pluang+

Cerenome reports safe repeat dosing of REYOBIQ in leptomeningeal metastases with early signs of disease control.

Company Fundamentals
16 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Bullish
Cerenome reports safe repeat dosing of REYOBIQ in leptomeningeal metastases with early signs of disease control.

Cerenome announced interim data from its ReSPECT-LM study showing that repeated intraventricular dosing of REYOBIQ in patients with leptomeningeal metastases is safe, with no dose-limiting toxicities in the first 10 patients. The study demonstrated consistent radiation delivery and early signals of disease control, with no progression at three and six months among evaluable patients. Dose escalation is ongoing, aiming to define a recommended multiple-dose regimen for a future randomized trial in 2027. These findings support the potential of fractionated dosing to deliver higher cumulative radiation doses with manageable side effects.

Cerenome's interim ReSPECT-LM data on repeat dosing of REYOBIQ provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 16, 2026 18:12 WIB: out of 150 priced US health-sector stocks, 66 rose and 50 fell today. Notable movers include HUM (Humana Inc) at USD 463.97 with a 3.10% increase and a typical hold time of 52 days, TNGX (Tango Therapeutics Inc.) at USD 24.75 down 2.94% with a 5-day hold, and HIMS (Hims and Hers Health Inc) at USD 19.20 down 2.71% with a 24-day hold time.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App